We found that the expression level of SLC17A6, encoding VGLUT2, was lower in NPCs representing FXS + epilepsy phenotype when compared to FXS NPCs derived from donors without epilepsy and control NPCs at all studied time points (Figure 5B), but the result did not reach statistical significance when adjusted for multiple comparisons. Here, SLC17A6 is linked to fragile X syndrome.